GRAND RAPIDS - Van Andel Research Institute announced Wednesday that Nobel Laureate Michael S. Brown, M.D., will give a special scientific seminar Oct. 27 called A Century of Cholesterol and Coronaries at the Institute. Brown was awarded the Nobel Prize in Medicine or Physiology in 1985 along with his colleague, Dr. Joseph L. Goldstein, for
LANSING - An additional four health insurance companies will offer coverage for Michigan residents in the federal marketplace in 2015, figures from the federal Department of Health and Human Services showed, bringing to 16 the number of companies that residents will be able to shop for insurance. Michigan is one of seven stats in the
LANSING - As part of an international court settlement, Michigan will get more than $1.6 million in a case where the U.S. subsidiary of an Irish company was charged with improperly promoting its drugs approved to treat attention deficit hyperactivity disorder to also treat ulcerative colitis. The settlement affects Shire Pharmaceuticals of Pennsylvania, which is
GRAND RAPIDS - Van Andel Research Institute has partnered with UK-based research charity The Cure Parkinson?s Trust on an initiative to identify new treatments for Parkinson?s disease. The collaboration, called the Linked Clinical Trials initiative, is aimed at repositioning medications approved to treat other diseases, which have also shown promise in slowing or reversing Parkinson?s
LANSING - The percentage of Michiganders without health insurance fell in 2013 from 11.4 percent to 11 percent, according to census data released Tuesday. According to the data, circulated by the Michigan League for Public Policy, 1,072,000 residents did not have health insurance in 2013. But the league said that number will fall much substantially
ANN ARBOR - Kicking off BioArbor?s Fall 2014 season, Carol Gallagher, past CEO of Calistoga Pharmaceuticals will present the story of the development of Zydelig and the formation and successful exit of Calistoga Pharmaceuticals on Sept. 18 at the University of Michigan North Campus Research Complex. Come hear her drug development and venture-backed company development
DETROIT ? The early bird special price of only $199 to attend the MichBio Expo at MotorCity Casino Hotel in Detroit ends Sept. 5. Then the price goes up to $249. The program includes: Keynote address by FDA Commissioner Margaret A. Hamburg, MD Plenary Luncheon with remarks by Joseph V. Gulfo, MD, MBA of Breakthrough
DETROIT - Just announced by MichBio, Joseph Gulfo, author of the Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances, has been named the plenary speaker for the MichBio Expo Sept. 30-Oct. 1 at the Motor City Casino. Gulfo is CEO of Breakthrough Medical Innovations, a team of biopharma and medtech consultants. An
ANN ARBOR - Is your company a bioscience start-up looking for exposure and support? Then apply for the MichBio Emerging Bioscience Showcase, a fast-paced competition of ten emerging, seed, and early-stage companies. Applications are due Aug. 29. Qualified ventures will include those evolving out of technology transfer offices or companies taking their first steps along
ANN ARBOR ? MichBio, the state?s Life Sciences trade association, has posed four new jobs in its career center ? VP Clinical Development & Medical Director, Manager Business Development, Metrology Technician, and Process Engineer. Vice President, Clinical Development & Medical Director Esperion Therapeutics, Inc. - Ann Arbor Esperion seeks to recruit a highly qualified individual